PandemieGrippaleV1, PubMed, Curation, bibRecord, 000180

Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.

Identifieur interne : 000180 ( PubMed/Curation ); précédent : 000179; suivant : 000181

Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.

Auteurs : Michelle F. Rourke

Source :

The Milbank quarterly [ 1468-0009 ] ; 2019.

RBID : pubmed:30637812

Descripteurs français

KwdFr :
- Accord transfert malade, Coopération internationale, Grippe humaine (), Humains, Organisation mondiale de la santé, Orthomyxoviridae, Pandémies (), Prélèvement biologique (normes), Santé mondiale.
MESH :
- normes : Prélèvement biologique.
- Accord transfert malade, Coopération internationale, Grippe humaine, Humains, Organisation mondiale de la santé, Orthomyxoviridae, Pandémies, Santé mondiale.

English descriptors

KwdEn :
- Global Health, Humans, Influenza, Human (prevention & control), International Cooperation, Orthomyxoviridae, Pandemics (prevention & control), Specimen Handling (standards), Transfer Agreement, World Health Organization.
MESH :
- prevention & control : Influenza, Human, Pandemics.
- standards : Specimen Handling.
- Global Health, Humans, International Cooperation, Orthomyxoviridae, Transfer Agreement, World Health Organization.

Abstract

Policy Points Securing access to pathogen samples for research purposes is crucial for pandemic preparedness and responding to infectious disease outbreaks. The Pandemic Influenza Preparedness Framework (PIP Framework) is the only pathogen-specific international access and benefit-sharing (ABS) instrument. This analysis reveals that during an influenza pandemic, the PIP Framework will safeguard access to virus samples but may not be as effective in delivering the associated benefits, like vaccines and antivirals, to countries in need. The PIP Framework's deficiencies must be addressed before an influenza pandemic and before this ABS model is extended to other human pathogens.

DOI: 10.1111/1468-0009.12364
PubMed: 30637812

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000180

Links to Exploration step

pubmed:30637812

Curation

No country items

Michelle F. Rourke

<affiliation><nlm:affiliation>Griffith Law School, Griffith University and Australian Defence Force Malaria and Infectious Disease Institute.</nlm:affiliation>
<wicri:noCountry code="subField">Griffith University and Australian Defence Force Malaria and Infectious Disease Institute</wicri:noCountry>
</affiliation>

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.</title>
<author><name sortKey="Rourke, Michelle F" sort="Rourke, Michelle F" uniqKey="Rourke M" first="Michelle F" last="Rourke">Michelle F. Rourke</name>
<affiliation><nlm:affiliation>Griffith Law School, Griffith University and Australian Defence Force Malaria and Infectious Disease Institute.</nlm:affiliation>
<wicri:noCountry code="subField">Griffith University and Australian Defence Force Malaria and Infectious Disease Institute</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30637812</idno>
<idno type="pmid">30637812</idno>
<idno type="doi">10.1111/1468-0009.12364</idno>
<idno type="wicri:Area/PubMed/Corpus">000180</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000180</idno>
<idno type="wicri:Area/PubMed/Curation">000180</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000180</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.</title>
<author><name sortKey="Rourke, Michelle F" sort="Rourke, Michelle F" uniqKey="Rourke M" first="Michelle F" last="Rourke">Michelle F. Rourke</name>
<affiliation><nlm:affiliation>Griffith Law School, Griffith University and Australian Defence Force Malaria and Infectious Disease Institute.</nlm:affiliation>
<wicri:noCountry code="subField">Griffith University and Australian Defence Force Malaria and Infectious Disease Institute</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">The Milbank quarterly</title>
<idno type="eISSN">1468-0009</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Global Health</term>
<term>Humans</term>
<term>Influenza, Human (prevention & control)</term>
<term>International Cooperation</term>
<term>Orthomyxoviridae</term>
<term>Pandemics (prevention & control)</term>
<term>Specimen Handling (standards)</term>
<term>Transfer Agreement</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accord transfert malade</term>
<term>Coopération internationale</term>
<term>Grippe humaine ()</term>
<term>Humains</term>
<term>Organisation mondiale de la santé</term>
<term>Orthomyxoviridae</term>
<term>Pandémies ()</term>
<term>Prélèvement biologique (normes)</term>
<term>Santé mondiale</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Prélèvement biologique</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Specimen Handling</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Global Health</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Orthomyxoviridae</term>
<term>Transfer Agreement</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Accord transfert malade</term>
<term>Coopération internationale</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Organisation mondiale de la santé</term>
<term>Orthomyxoviridae</term>
<term>Pandémies</term>
<term>Santé mondiale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Policy Points Securing access to pathogen samples for research purposes is crucial for pandemic preparedness and responding to infectious disease outbreaks. The Pandemic Influenza Preparedness Framework (PIP Framework) is the only pathogen-specific international access and benefit-sharing (ABS) instrument. This analysis reveals that during an influenza pandemic, the PIP Framework will safeguard access to virus samples but may not be as effective in delivering the associated benefits, like vaccines and antivirals, to countries in need. The PIP Framework's deficiencies must be addressed before an influenza pandemic and before this ABS model is extended to other human pathogens.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30637812</PMID>
<DateCompleted><Year>2019</Year>
<Month>04</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-0009</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>97</Volume>
<Issue>1</Issue>
<PubDate><Year>2019</Year>
<Month>03</Month>
</PubDate>
</JournalIssue>
<Title>The Milbank quarterly</Title>
<ISOAbbreviation>Milbank Q</ISOAbbreviation>
</Journal>
<ArticleTitle>Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.</ArticleTitle>
<Pagination><MedlinePgn>91-112</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-0009.12364</ELocationID>
<Abstract><AbstractText>Policy Points Securing access to pathogen samples for research purposes is crucial for pandemic preparedness and responding to infectious disease outbreaks. The Pandemic Influenza Preparedness Framework (PIP Framework) is the only pathogen-specific international access and benefit-sharing (ABS) instrument. This analysis reveals that during an influenza pandemic, the PIP Framework will safeguard access to virus samples but may not be as effective in delivering the associated benefits, like vaccines and antivirals, to countries in need. The PIP Framework's deficiencies must be addressed before an influenza pandemic and before this ABS model is extended to other human pathogens.</AbstractText>
<AbstractText Label="CONTEXT">The World Health Organization (WHO) adopted the Pandemic Influenza Preparedness Framework (PIP Framework) after being forced to grapple with the demands of developing countries for the fairer distribution of vaccines and antivirals created using influenza viruses isolated from within their territories. Though adopted as a nonbinding resolution, the PIP Framework has been praised for its novel legal approach to access and benefit-sharing (ABS), using Standard Material Transfer Agreements (SMTAs) to create binding terms and conditions on both providers and users of PIP biological materials. The PIP Framework's SMTA1 regulates the movement of influenza viruses with human pandemic potential through the WHO's Global Influenza Surveillance and Response System (GISRS) as it operates to monitor the spread of seasonal influenza and detect the emergence of pandemic strains. Member States give consent to the WHO to transfer their materials to third parties under the terms of a negotiated SMTA2. The SMTA2 details benefits such as vaccines and antivirals to be made available to the WHO for distribution in the event of an influenza pandemic.</AbstractText>
<AbstractText Label="METHODS">I analyzed the PIP Framework, its SMTAs, and secondary sources to determine whether the PIP Framework will effectively function as an ABS instrument during an influenza pandemic.</AbstractText>
<AbstractText Label="FINDINGS">The SMTAs do not create any direct or binding agreements between Member States and third-party recipients of influenza viruses. In the lead-up to and during a pandemic, the SMTA1 secures access to influenza viruses for the WHO, and the SMTA2 secures access for commercial users of virus samples, but the SMTA2 may be ineffective in securing tangible benefits for the sovereign providers of those materials.</AbstractText>
<AbstractText Label="CONCLUSIONS">As the international community starts to consider how to best regulate access to nonpandemic influenza pathogen samples, it is imperative that we first address the shortcomings of the only pathogen-specific international ABS instrument available, and we should do so before it is put to the ultimate test.</AbstractText>
<CopyrightInformation>© 2019 Milbank Memorial Fund.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rourke</LastName>
<ForeName>Michelle F</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>Griffith Law School, Griffith University and Australian Defence Force Malaria and Infectious Disease Institute.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>01</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Milbank Q</MedlineTA>
<NlmUniqueID>8607003</NlmUniqueID>
<ISSNLinking>0887-378X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014164" MajorTopicYN="Y">Transfer Agreement</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">PIP Framework</Keyword>
<Keyword MajorTopicYN="Y">World Health Organization</Keyword>
<Keyword MajorTopicYN="Y">access and benefit-sharing</Keyword>
<Keyword MajorTopicYN="Y">genetic resources</Keyword>
<Keyword MajorTopicYN="Y">pandemic influenza</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30637812</ArticleId>
<ArticleId IdType="doi">10.1111/1468-0009.12364</ArticleId>
<ArticleId IdType="pmc">PMC6422609</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2008 Jan;14(1):88-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18258086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Acad Med Singapore. 2008 Jun;37(6):482-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18618060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2010 May 04;7(5):e1000247</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20454566</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2011 Jul 13;306(2):200-1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21750298</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(3):e33025</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22412979</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Law Med. 2012 Sep;20(1):59-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23156648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Res Policy Syst. 2013 Jun 24;11:22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23800108</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 May 1;370(18):1732-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24785208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 1995 Jan-Mar;1(1):7-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8903148</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000180 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000180 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30637812
   |texte=   Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30637812" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.

Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Curation

No country items

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki